<document xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:z="http://www.ebi.ac.uk/z" source="Whatizit"><text><SENT sid="0" pm="."><plain>The <z:e sem="disease" ids="C0027651" disease_type="Neoplastic Process" abbrv="">tumor</z:e> suppressor <z:mpath ids='MPATH_271'>adenomatous polyposis coli</z:mpath> (APC) has recently been implicated in parathyroid development </plain></SENT>
<SENT sid="1" pm="."><plain>We here report clinical, histopathological and molecular investigations in <z:e sem="disease" ids="C0030521" disease_type="Neoplastic Process" abbrv="">parathyroid tumors</z:e> arising in two patients; one <z:e sem="disease" ids="C0032580" disease_type="Neoplastic Process" abbrv="">familial adenomatous polyposis</z:e> (FAP) syndrome patient carrying a constitutional APC mutation, and one <z:e sem="disease" ids="C0009405" disease_type="Neoplastic Process" abbrv="">Lynch syndrome</z:e> patient demonstrating a germline MLH1 mutation as well as a non-classified, missense alteration of the APC gene </plain></SENT>
<SENT sid="2" pm="."><plain>We sequenced the entire APC gene in <z:e sem="disease" ids="C0027651" disease_type="Neoplastic Process" abbrv="">tumor</z:e> and constitutional DNA from both cases, assessed the levels of APC promoter 1A and 1B methylation by <z:chebi fb="0" ids="17137">bisulfite</z:chebi> Pyrosequencing analysis and performed immunohistochemistry for APC and parafibromin </plain></SENT>
<SENT sid="3" pm="."><plain>In addition, copy number analysis regarding the APC gene on chromosome 5q21-22 was performed using qRT-PCR </plain></SENT>
<SENT sid="4" pm="."><plain>Histopathological workup confirmed both <z:e sem="disease" ids="C0027651" disease_type="Neoplastic Process" abbrv="">tumors</z:e> as <z:hpo ids='HP_0002897'>parathyroid adenomas</z:hpo> without signs of <z:e sem="disease" ids="C1306459,C0006826" disease_type="Neoplastic Process" abbrv="">malignancy</z:e> or atypia </plain></SENT>
<SENT sid="5" pm="."><plain>No <z:hpo ids='HP_0001428'>somatic mutations</z:hpo> or copy number changes for the APC gene were discovered in the <z:e sem="disease" ids="C0027651" disease_type="Neoplastic Process" abbrv="">tumors</z:e>; however, in both cases, the APC promoter 1A was hypermethylated while the APC promoter 1B was unmethylated </plain></SENT>
<SENT sid="6" pm="."><plain>APC promoter 1B-specific <z:chebi fb="2" ids="33699">mRNA</z:chebi> and total APC <z:chebi fb="2" ids="33699">mRNA</z:chebi> levels were higher than in <z:mpath ids='MPATH_458'>normal</z:mpath> parathyroid samples </plain></SENT>
<SENT sid="7" pm="."><plain>Immunohistochemical analyses revealed strong APC protein immunoreactivity and positive parafibromin expression in both <z:e sem="disease" ids="C0030521" disease_type="Neoplastic Process" abbrv="">parathyroid tumors</z:e> </plain></SENT>
<SENT sid="8" pm="."><plain>Absence of additional somatic APC mutations and copy number changes in addition to the positive APC immunoreactivity obtained suggest that the <z:e sem="disease" ids="C0027651" disease_type="Neoplastic Process" abbrv="">tumors</z:e> arose without biallelic inactivation of the APC <z:e sem="disease" ids="C0027651" disease_type="Neoplastic Process" abbrv="">tumor</z:e> suppressor gene </plain></SENT>
<SENT sid="9" pm="."><plain>The finding of an unmethylated APC promoter 1B and high APC 1B <z:chebi fb="2" ids="33699">mRNA</z:chebi> levels could explain the maintained APC protein expression </plain></SENT>
<SENT sid="10" pm="."><plain>Moreover, the findings of positive parafibromin and APC immunoreactivity as well as a low MIB-1 proliferation index and absence of histopathological features of <z:e sem="disease" ids="C1306459,C0006826" disease_type="Neoplastic Process" abbrv="">malignancy</z:e>/atypical <z:mpath ids='MPATH_270'>adenoma</z:mpath> indicate that the <z:hpo ids='HP_0002897'>parathyroid adenomas</z:hpo> arising in these patients did not harbor malignant potential </plain></SENT>
</text></document>